Nerve Conduction Studies and Electromyography
J9 · Effective Oct 1, 2015
15 active Medicare policies list R39.15, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Nov 5, 2023
JM · Effective Nov 5, 2023
JL · Effective Oct 1, 2025
3 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of R39.15 |
|---|---|---|
| Pulsed Radiofrequency | Sep 20, 2023 | Covered |
| Transvaginal Ultrasonography | Aug 8, 2023 | Covered |
| Policy | Effective | Status of R39.15 |
|---|---|---|
| Cancer Antigen 125 Testing | Oct 1, 2026 | Covered |
J9 · Effective Oct 1, 2025
National · Effective Mar 26, 2026
J6 · Effective Apr 1, 2026
National · Effective Jun 17, 2025
National · Effective Apr 6, 2026
National · Effective Mar 5, 2026